Literature DB >> 20424769

A pH-responsive fluorescence probe and photosensitiser based on a tetraamino silicon(IV) phthalocyanine.

Xiong-Jie Jiang1, Pui-Chi Lo, Sin-Lui Yeung, Wing-Ping Fong, Dennis K P Ng.   

Abstract

A novel tetraamino silicon(iv) phthalocyanine has been prepared, of which the fluorescence emission and reactive oxygen species generation efficiency are greatly enhanced at lower pH in the range of ca. 5-7, making it a promising pH-controlled and tumour-selective fluorescence probe and photosensitiser for photodynamic therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20424769     DOI: 10.1039/c000605j

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  12 in total

1.  Photoactivation switch from type II to type I reactions by electron-rich micelles for improved photodynamic therapy of cancer cells under hypoxia.

Authors:  Huiying Ding; Haijun Yu; Ying Dong; Ruhai Tian; Gang Huang; David A Boothman; Baran D Sumer; Jinming Gao
Journal:  J Control Release       Date:  2011-08-23       Impact factor: 9.776

2.  Novel Silicon Phthalocyanines Bearing Triethylene Glycol Groups: Photophysical and Photochemical Properties as well as pH-Induced Spectral Behaviour.

Authors:  Sebile Işık Büyükekşi; Sevinc Zehra Topal; Devrim Atilla
Journal:  J Fluoresc       Date:  2017-03-30       Impact factor: 2.217

Review 3.  The subcellular distribution of small molecules: from pharmacokinetics to synthetic biology.

Authors:  Nan Zheng; Hobart Ng Tsai; Xinyuan Zhang; Gus R Rosania
Journal:  Mol Pharm       Date:  2011-08-15       Impact factor: 4.939

Review 4.  Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy.

Authors:  Zijian Zhou; Jibin Song; Liming Nie; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2016-11-21       Impact factor: 54.564

5.  A Tumor-pH-Responsive Supramolecular Photosensitizer for Activatable Photodynamic Therapy with Minimal In Vivo Skin Phototoxicity.

Authors:  Xingshu Li; Bi-Yuan Zheng; Mei-Rong Ke; Yongfan Zhang; Jian-Dong Huang; Juyoung Yoon
Journal:  Theranostics       Date:  2017-07-07       Impact factor: 11.556

6.  New application of phthalocyanine molecules: from photodynamic therapy to photothermal therapy by means of structural regulation rather than formation of aggregates.

Authors:  Xingshu Li; Xiao-Hui Peng; Bing-De Zheng; Jilin Tang; Yuanyuan Zhao; Bi-Yuan Zheng; Mei-Rong Ke; Jian-Dong Huang
Journal:  Chem Sci       Date:  2018-01-08       Impact factor: 9.825

7.  Selective Detection of Trinitrophenol by Amphiphilic Dimethylaminopyridine-Appended Zn(II)phthalocyanines at the Near-Infrared Region.

Authors:  S Kasthuri; Pratiksha Gawas; Samarendra Maji; N Veeraiah; N Venkatramaiah
Journal:  ACS Omega       Date:  2019-04-03

8.  Far-red light activatable, multifunctional prodrug for fluorescence optical imaging and combinational treatment.

Authors:  Moses Bio; Pallavi Rajaputra; Gregory Nkepang; Youngjae You
Journal:  J Med Chem       Date:  2014-04-14       Impact factor: 7.446

9.  Folate-PEG Conjugates of a Far-Red Light-Activatable Paclitaxel Prodrug to Improve Selectivity toward Folate Receptor-Positive Cancer Cells.

Authors:  Pritam Thapa; Mengjie Li; Radha Karki; Moses Bio; Pallavi Rajaputra; Gregory Nkepang; Sukyung Woo; Youngjae You
Journal:  ACS Omega       Date:  2017-10-04

Review 10.  Controllable Photodynamic Therapy Implemented by Regulating Singlet Oxygen Efficiency.

Authors:  Wenting Wu; Xiaodong Shao; Jianzhang Zhao; Mingbo Wu
Journal:  Adv Sci (Weinh)       Date:  2017-06-23       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.